Emelia Hunt advises on a wide range of corporate transactions, including private mergers and acquisitions (both domestic and cross-border), public takeovers, IPOs, fundraisings, joint ventures, restructurings and private equity-back transactions, as well as corporate advisory work. Emelia has also been involved in a number of life sciences transactions, including the global distribution of the covid-19 vaccine for two major pharmaceutical companies.

Emelia represents clients across a broad range of sectors, including financial services, real estate, and insurance, but has a particular interest in and focus on healthcare, life sciences and technology.

Emelia is also active in pro bono work at the firm. In 2021 she successfully represented a pro bono client in a building dispute in court and is currently assisting a family with their immigration applications.


  • West Texas Eye, Cataract Surgical Center of Lubbock, and Lubbock LaserVision Center on the sale of certain assets of West Texas Eye’s ophthalmology practice, and the equity of Cataract Surgical Center of Lubbock and Lubbock LaserVision Center, to American Vision Partners (AVP), an affiliate of private equity firm H.I.G. Capital.
  • Omega Healthcare Investors, Inc., in a number of transactions concerning its acquisition and lease of UK healthcare facilities and general corporate advisory work.
  • Touchlight Genetics on renegotiated license with AskBio and joint venture exit.
  • Wheels Up Experience, Inc. on its recommended all-cash acquisition by way of a scheme of arrangement of Air Partner plc, a publicly listed company on the London Stock Exchange.
  • Touchlight, on various corporate matters, including fundraising from private equity.
  • Mark G. Anderson Consultants Inc., on its acquisition of London-based property and construction consultants Robinson Low Francis LLP.
  • Better HoldCo Inc., a US-based digital homeownership platform, in its acquisition of the UK-based digital mortgage and insurance broker Trussle.
  • AstraZeneca, in agreements with governmental authorities for the distribution of the University of Oxford's COVID-19 vaccine.
  • Pfizer, in agreements for the supply to various governmental authorities of Pfizer and BioNTech’s mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2.
  • Steering committee of term loan lenders owed in excess of $2 billion with respect to the issuance of a new $450 million term loan facility to Cineworld Group Plc (Cineworld), a publicly listed company on the London Stock Exchange and the world's second-largest cinema chain.


A Beginner’s Guide to Life Sciences M&A Deals
Arnold & Porter Webinar


  • American Law and Politics, University of Southern California, 2016
  • MA, Law, Queens' College, Cambridge, 2015
  • England and Wales

Email Disclaimer